Difficulties in diagnosis of atypical haemolytic uremic syndrome in a patient with partial (incomplete) thrombotic microangiopathy
Abstract
About the Authors
N. L. KozlovskayaRussian Federation
N. V. Chebotareva
Russian Federation
A. D. Nikogosova
Russian Federation
K. A. Demyanova
Russian Federation
V. A. Varshavsky
Russian Federation
S. V. Roshupkina
Russian Federation
References
1. Козловская Н.Л., Демьянова К.А., Кузнецов Д.В. и др. «Субклиническая» тромботическая микроангиопатия при атипичном гемолитико-уремическом синдроме: единичный случай или закономерность? Нефрология и диализ. 2014. 16(2): 280-287. (Kozlovskaya N.L., Demyanova K.A., Kuznetsov D.V. et al. Atypical haemolytic uremic syndrome with “subclinical” thrombotic microangiopathy: a single case or regularity? Nephrology and Dialysis. 2014. 16(2): 280-287. Transl. from Russian).
2. Akhtar R., Triolo D. A case report of atypical hemolytic uremic syndrome presenting with massive proteinuria. Am J Med Case Report. 2015. 3(9): 278-281.
3. Ariceta G., Besbas N., Johnson S. et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009. 24: 687-696.
4. Campistol J.M., Arias M., Ariceta G. et al. An update for atypical haemolytic uremic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2013. 33: 27-45.
5. Fremeaux-Bacchi V., Fakhouri F., Garnier A. et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013. 8: 554-562.
6. Kaplan B.S., Meyers K.E., Schulman S.L. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol. 1998. 9(6): 1126-1133.
7. Nester C.M., Thomas C.P. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program. 2012. 2012(1): 617-25.
8. Noris M., Caprioli J., Bresin E. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010. 5(10): 1844-59.
9. Noris M., Mele C., Remuzzi G. Podocyte dysfunction in atypical haemolytic uremic syndrome. Nat Rev Nephrol. 2015. 11(4): 245-52.
10. Noris M., Remuzzi G. Atypical haemolytic-uremic syndrome. N Engl J Med. 2009. 361: 1676-1687.
11. Ruggenenti P., Noris M., Remuzzi G. Trombotic mocroangiopathy, haemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int. 2001. 60: 831-846.
12. Sallee M., Ismail K., Fakhouri F. et al. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome. BMC Nephrology. 2013. 14(3): 1471-2369.
13. Sellier-Leclerc A.L., Fremeaux-Bacchi V., Dragon-Durey M.A. et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007. 18 (8): 2392-2400.
14. De Serres SA, Isenring P. Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrol Dial Transplant. 2009. 24: 1048-1050.
Review
For citations:
Kozlovskaya N.L., Chebotareva N.V., Nikogosova A.D., Demyanova K.A., Varshavsky V.A., Roshupkina S.V. Difficulties in diagnosis of atypical haemolytic uremic syndrome in a patient with partial (incomplete) thrombotic microangiopathy. Nephrology and Dialysis. 2016;18(3):328-336. (In Russ.)